Seeing Is Believing
Currently out of the existing stock ratings of Priya Sachdeva, 9 are a BUY (60%), 6 are a HOLD (40%).
Analyst Priya Sachdeva, currently employed at UBS, carries an average stock price target met ratio of 55.56% that have a potential upside of 22.8% achieved within 191 days.
Priya Sachdeva’s has documented 29 price targets and ratings displayed on 3 stocks. The coverage is on the Healthcare sector.
Most recent stock forecast was given on MDT, Medtronic PLC at 03-Sep-2026.
Analyst best performing recommendations are on NPCE (NEUROPACE).
The best stock recommendation documented was for NPCE (NEUROPACE) at 1/21/2025. The price target of $17 was fulfilled within 114 days with a profit of $3.94 (30.17%) receiving and performance score of 2.65.
Average potential price target upside
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date of last PT
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Buy Since 28-May-2025
$20
$7.33 (57.85%)
$20
2 months 12 days ago
(29-Jul-2026)
2/4 (50%)
$6.36 (46.63%)
222
Buy Since 27-May-2025
$20
$7.33 (57.85%)
8 months 9 days ago
(02-Feb-2026)
0/2 (0%)
$4.09 (25.71%)
Buy Since 21-Jan-2025
$22
$9.33 (73.64%)
$22
8 months 27 days ago
(14-Jan-2026)
2/4 (50%)
$5.25 (31.34%)
221
Buy Since 08-Nov-2023
$20
$3.53 (21.43%)
$16
10 months 1 days ago
(10-Dec-2025)
4/5 (80%)
$3.22 (19.19%)
126
Buy Since 29-May-2024
$16
$-0.47 (-2.85%)
$15
11 months 6 days ago
(05-Nov-2025)
7/10 (70%)
$3.02 (23.27%)
146
Which stock is Priya Sachdeva most bullish on?
What Year was the first public recommendation made by Priya Sachdeva?